Translational Development Acquisition (TDAC) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Translational Development Acquisition Revenue Highlights


00

Translational Development Acquisition Revenue by Period


Translational Development Acquisition Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--

Translational Development Acquisition generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Translational Development Acquisition Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$191.76K-14.33%
2025-03-31$223.85K100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-05-31--

Translational Development Acquisition generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Translational Development Acquisition Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
FACTFACT II Acquisition$108.74M-
CEPCantor Equity Partners, Inc. Class A Ordinary Shares--
MACIMelar Acquisition Corp. I--
TDACTranslational Development Acquisition--
HCMAHCM Acquisition--
SZZLSizzle Acquisition Corp. II--

TDAC Revenue FAQ


What is Translational Development Acquisition’s yearly revenue?

Translational Development Acquisition's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. TDAC's yearly revenue for 2022 was $0, representing an increase of 0% compared to 2021.

What is Translational Development Acquisition’s quarterly revenue?

Translational Development Acquisition's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $191.76K, a -14.33% decrease from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). TDAC's quarterly revenue for Q1 2025 was $223.85K, a 100.00% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Translational Development Acquisition’s revenue growth rate?

Translational Development Acquisition's revenue growth rate for the last 3 years (2022-2024) was 0%